Afya combines strong financial momentum with a powerful strategic position. Revenues, profits, and cash flows have all grown meaningfully, backed by high and stable margins. The balance sheet shows rising equity and retained earnings, and operating cash generation is robust. Strategically, the company benefits from a scarce and regulated resource—medical school seats in Brazil—plus an increasingly integrated digital ecosystem that accompanies physicians throughout their careers. Its innovation efforts, particularly in AI and data‑driven tools, further enhance engagement and differentiation.

The main risks center on leverage, acquisition intensity, and dependence on regulation and local conditions. Debt has risen substantially, liquidity cushions have narrowed compared with earlier years, and the asset base is heavily weighted toward goodwill and intangibles, which could be vulnerable if acquisitions underperform. Regulatory shifts could weaken the current scarcity value of medical seats or change funding dynamics. Competitive and technological risks in digital health and education are also material, especially if rivals innovate faster or global players intensify their presence in Brazil.

Based on current trends, Afya appears positioned for continued growth, supported by strong demand for medical education, a leading market position, and expanding digital services. Its improving free cash flow offers flexibility to invest, manage debt, and strengthen its financial footing. The quality of future results will likely hinge on disciplined capital allocation, successful integration of acquired assets, and sustained innovation in its digital ecosystem. While the trajectory is favorable, the higher leverage and regulatory and competitive dependencies mean that the company’s future performance could be sensitive to shifts in the operating or policy environment.